Intercept Pharmaceuticals Company

Intercept Pharmaceuticals develops small molecule drugs and therapeutics for the treatment of chronic fibrotic and metabolic diseases.

Funding Status: IPO
Employee Number: 501-1000
Estimated Revenue: $50M to $100M
Technology: Cancer
Founded Date: 2002
Headquarters: United States
Industry: Metabolism Dysfunctions